The impact of residual renal function on the adequacy of peritoneal dialysis

Nephron

Volumn 77, Issue 1, 1997, Pages 13-28

  Lameire, N H ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CARDIOVASCULAR DISEASE; CASE REPORT; HUMAN; KIDNEY CLEARANCE; KIDNEY FUNCTION; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REVIEW;

EID: 0030779949     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190242     Document Type: Article

References (99)

1. Port FK, Held PJ, Nolph KD, et al: Risk of peritonitis and technique failure by CAPD connection technique: A national study. Kidney Int 1992:42:967.
2. Viglino G, Cantaluppi A, Gandolfo C, Peluso F, C'avalli PL: Y-set evolution: in La Greca G, Ronco C, Fcriani M, Chiaramontc S, Conz P (eds): Peritoneal Dialysis. Milan. Wichtig. 1991, pp 281-293.
3. Popovich RP, Moncrief JW, Decherd JF, Bo-mar JB, Pyle WK: The definition of a novel portable/wearable equilibrium dialysis technique (abstract). Trans Am Soc Artif Int Organs 1976:5:64.
4. Popovich RP, Moncrief JW, Decherd JF, Pyle WK, Morris S, Lindlev JD: Clinical developments of the low dialysis clearance hypothesis via equilibrium peritoneal dialysis. Proc Annual Contractors Conf Artif Kidney - Chronic Uremia Prog (NI AM DO) 1977;10:123-125.
5. Rose BD: Clinical Physiology of Acid-Base and Electrolyte Disorders, ed 4. New York. McGraw-Hill. 1994. pp 48-55.
6. Payne RB: Creatinine clearance: A redundant clinical investigation. Ann Clin Biochem 1986; 23:243-250.
7. Doolan PD, Alpen EL, Theil GB: A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med 1962:32:65-79.
8. Kim KE, Onesti G, Ramirez O, Brest AN, Swartz C: Creatinine clearance in renal disease. A reappraisal. Br Med J 1969:iv: 11-14.
9. Levey AS: Measurement of renal function in chronic renal disease. Kidney Int 1990:38:167-184.
10. Van Acker BAC, Koomen GCM, Koopman MG, de Waart DR, Arisz L: Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet 1992;340:1326-1329.
11. Petri M, Bockenstedt L, Colman J, et al: Serial assessment of glomerular nitration rate in lupus nephropathy. Kidney Int 1988:34:832-839.
12. 99mTc-DTPA. and inulin. Am J Kidney Dis 1990:16: 224-235.
13. Hilbrands LB, Artz MA, Wetzels JF. Kocne RA: Cimetidine improves the reliability of creatinine as a marker of glomerular filtration. Kidney Int 1991:40:1171-1176.
14. Hiratadulas CAI, Halstcnson CE, Kasiske BL: Improvement in the accuracy and precision of creatinine clearance as a measure of glomerular filtration rate with oral cimetidine in renal transplant recipients. Clin Transplant 1993:7: 552-558.
15. Agarwal R: Creatinine clearance with cimetidine for measurement of GFR (letter). Lancet 1993:341:188.
16. Lubowitz H, Slatopolsky E, Shankel S, et al: Glomerular filtration rate determination in patients with chronic renal disease. JAMA 1967: 199:252.
17. Van Olden RW, Krediet RT, Struijk DC, Arisz L: Measurement of residual renal function in patients treated with CAPD (abstract). Sixth Benelux Dial Symp. Brussels 1995.
18. Milulinovic J, Cutler RE, Hoover P, Meusen B, Scribner BH: Measurement of glomerular filtration rate in patients receiving repetitive hemodialysis. Kidney Int 1975:8:185-190.
19. Gaspari F, Perico N, Ruggenenti P, et al: Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 1995:6:257-263.
20. Swan SK, Halstenson CE, Kasiske BL, Collins AJ: Determination of residual renal function with iohexol clearance in hemodialysis patients. Kidney Int 1996:49:232-235.
21. Marx MA, Shuler CL, Tallersall JE, Golper TA: Plasma iohexol clearance as an alternative to creatinine clearance for CAPD adequacy studies. Kidney Int 1995:48:1994-1997.
22. Rottembourg J, Issad B, Gallego JL, Degoulet P, Aime F, Gueffaf B, Legrain M: Evolution of residual renal function in patients undergoing maintenance hemodialysis or continuous ambulatory peritoneal dialysis. Proc EDTA 1983; 19:397-403.
23. Nolph KD: Is residual renal function better preserv ed with CAPD than with hemodialysis? Am Kidney Fund Nephrol Lett 1990;7:1-7.
24. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, Nolph KD, Pollock CA, Prowant B, Farrel PC: The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991:37:598-604.
25. Rottembourg J: Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int 1993:43(suppl 40): 106-110.
26. lest CG, Vanholder RC, Ringoir SM: Loss of residual renal function in patients on regular hemodialysis. Int J Artif Organs 1989:12:154-159.
27. Hiroshige K, Yuu K, Soejima M, Takasugi M, Kuroiwa A: Rapid decline of residual renal function in patients on automated peritoneal dialysis. Pcrit Dial Int 1996:16:307-315.
28. McCarthy JT: The use of polysulfone dialyzers slows the rate of intrinsic renal function loss in chronic hemodialysis patients (abstract). J Am Soc Nephrol 1993:4:367.
29. McKane WS, Tattersall JE, Farrington K: Preservation of residual renal function in high flux hacnodialysis (abstract). Nephrol Dial Transplant 1994:9:1686.
30. Schifl H: Choice of dialysis membrane does not influence the outcome of residual renal function in haentodialysis patients (letter). Nephrol Dial Transplant 1995:10:611-612.
31. Van Stone JC: The effect of dialyzer membrane and etiology of kidney disease on the preservation of residual renal function in chronic hemodialysis patients. ASAIO J 1995:41:M713-M716.
32. Caramclo C, Alcazar R, Gallar P, et al: Choice of dialysis membrane docs not influence the outcome of residual renal function in haemodi-alysis patients. Nephrol Dial Transplant 1994: 9:675-677.
33. Caro J, Brown S, Miller O, Murray TG, Erslev AJ: Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med 1979;93:449-454.
34. Zappacosta AR, Caro J, Erslev A: Normalization of hematocrit in patients with end-stage renal disease on CAPD. The role of erythropoietin. Am J Med 1982:72:53-57.
35. Chandra M, Clemons GK, McVicar M, Wilkes B, Mosscy RT: Scrum erythropoietin levels and hematocrit in end-stagc renal disease: Influence of the mode of therapy. Am J Kidney Dis 1988;12:208-213.
36. Jongen MJM, Van der Vijgh WSF, Lip P, N'etelenbos JC: Measurements of vitamin D metabolites in anephric subjects. Nephrol 1984:36:230-236.
37. Blumbcrg A, Burgi W: Behaviour of P-micro-globulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis. Clin Nephrol 1987:27:245-249.
38. Rottenibourg J, Allouache M, Mussev L, Jacobs C: Beta-2-microglobulin in dialyzed patients: Hemodialysis versus continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1987;2:248-249.
39. Thielemans C, Dratwa M, Bergmann P, Goldman M, Flamion B, Collart F, Wens R: Continuous ambulatory peritoneal dialysis versus hae-modialvsis: A lesser risk of amyloidosis. Nephrol Dial Transplant 1988:3:291-294.
40. Acchiacardo S, Krau AP, Jennings BR: Beta-2-microglobulin levels in patients with renal insufficiency. Am J Kidney Dis 1989:13:70-74.
41. Scalamogna A, Imbasciati E, Dcvccchi A, Cas-telnovo C, Pagliari B, De Christofaro V, Ponti-cclli C: Beta-2-microglobulin in patients on peritoneal dialysis and hemodialysis. Peril Dial int 1989:9:37-40.
42. 2-Microglobulin in CAPD. Adv Peril Dial 1992;8:369-372.
43. Amici G, Virga G, Da Rin G, et al: Serum beta-2-microglobulin level and residual renal function in peritoneal dialysis. Nephron 1993:65: 469-471.
44. Tielemans C, Dratwa M, Bergmann P, et al: Continuous ambulatory peritoneal dialysis: A lesser risk of amvloidosis? Nephrol Dial Transplant 1988:3:291-294.
45. Kcshaviah P: Adequacy of CAPD: A quantitative approach. Kidney Int 1992:42:(suppl 38): 160-164.
46. Nolph KD, Twardowski ZJ, Kcshaviah PR: Weekly clearances of urea and creatinine on CAPD and NIPD. Perit Dial Int 1992,12:298-303.
47. Churchill DN, Taylor DW, Keshaviah P: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcome. J Am Soc Nephrol 1996:7:198-207.
48. Taller B, Lemeire N: Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years. Nephrol Dial Transplant 1994:9:280-286.
49. Lameirc N, Vanholder R, Vijt D, Lambert MC, Ringoir S: A longitudinal five-year survey of urea kinetic parameters in CAPD patients. Kidney Int 1992:42:426-432.
50. Watson PE, Watson ID, Ball RD: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980:33:27-39.
51. Keshaviah P, Nolph KD: The peak concentration hypothesis: A urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis and hemodialysis. Pcrit Dial Int 1989:9:257-260.
52. Ronco C, Conz P, Agostini F, Bosch JP, Lew SQ, La Greca G: The concept of adequacy of peritoneal dialysis. Peril Dial Int 1994:14 (suppl 3):93-98
53. Keshaviah P: Can peritoneal dialysis be equivalent to (or better than) optimal hemodialysis? Semin Dial 1996;9:243-245.
54. Keshaviah P, Emerson PF, Vonesh EF, Brandes JC: Relationship between body size fill volume, and mass transfer area coefficient in peritoneal dialysis. J Am Soc Nephrol 1994: 4:1820-1826.
55. Blake PG: Targets in CAPD and APD prescription. Perit Dial Int 1996; 16:S143-S146.
56. Tattersall JE, Doyle S, Greewood RN, Farrington K: Maintaining adequacy in CAPD by individualizing the dialysis prescription. Nephrol Dial Transplant 1994:9:749-752.
57. Johnston JR, Bernardini J, Holley H, Piraino B: Effect of increasing exchange volume or frequency on CAPD efficiency (abstract). Perit Dial Int 1995; 15:S41.
58. Diaz-Buxo JA. Suki WN: Automated peritoneal dialysis: in Gokal R. Nolph KD (eds): The Textbook of Peritoneal Dialysis. Dordrecht. Kluwer Academic Publishers. 1994. pp 399-418.
59. De Fijter CW, Oe LP, Nauta JJ, et al: Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med 1994: 120:264-271.
60. Brunkhorst R, Wrenger F, Krautzig S, Ehler-ding G, Mahiout A, Koch KM: Clinical experience with home automated peritoneal dialysis. Kidney Int 1994:46(suppl 48):25-30.
61. Twardowski Z, Nolph KD: Is peritoneal dialysis feasible once a large muscular patient becomes anuric? Pcrit Dial Int 1996:16:20-23.
62. Lameire N, Bernaert P, Lambert MC, Vijt D: Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1994;46(suppl 48):31-38.
63. Lameire N, Vanholder R, Van Loo A, et al: Cardiovascular diseases in peritoneal dialysis patients: The size of the problem. Kidney Int 1996;50(suppl 56):28-36.
64. Parfrey S, Harnett JD, Foley RN: Heart failure and ischemic heart disease in chronic uremia. Curr Opin Nephrol Hypertens 1995:4:105-110.
65. Amann K, Ritz E: Cardiac structure and function in renal disease. Curr Opin Nephrol Hypertens 1996:5:102-106.
66. Alpert MA, Hüting J, Twardowski ZJ, Khanna R, Nolph KD: Continuous ambulatory peritoneal dialysis and the heart. Perit Dial Int 1995; 15:6-11.
67. Cullelon B, Parfrey PS; Cardiovascular risk in continuous ambulatory peritoneal dialysis. Perit Dial Int 1996;16:10-12.
68. Churchill DN: Can peritoneal dialysis be equivalent to (or better than) optimal hemodialysis? Semin Dial 1996:9:240-241.
69. Gotch F, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study. Kidney Int 1985:28:526-534.
70. Keshaviah P, Ma J, Thorpe K, Churchill D, Collins A: Comparison of 2-year survival on hemodialysis and peritoneal dialysis with a dose of dialysis matched using the peak concentration hypothesis (abstract). J Am Soc Nephrol 1995:6:540.
71. Saldanha LF, Weiler E, Gonick HC: Effect of continuous ambulatory peritoneal dialysis on blood pressure control. Am J Kidney Dis 1993: 21:184-188.
72. Charra B, Calemard E, Ruffet M. Chazot C, Terrat JC, Vanel T, Laurent G: Survival as an index of adequacy of dialysis. Kidney Int 1992: 41:1286-1291.
73. Charra B, Calemard E, Laurent G: Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996:16:35-44.
74. Tzamaloukas AH, Saddler MC, Murata GH, et al: Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am Soc Nephrol 1995:6:198-206.
75. Mulcc H, Blohme G, Kullenberg K, Nyberg G, Bjorck S: Latent overhydration and nocturnal hypertension in diabetic nephropathy. Diabe-tologia 1995;38:216-220.
76. Davies SJ, Bryan J, Phillips L, Russel GI: The predictive value of Kt/V and peritoneal solute transport in CAPD patients is dependent on the type of comorbidity present. Pcrit Dial Int 1996:16(suppl I): 158-162.
77. Heimburger O, Waniewski J, Wervnski A, Tra-naeus A, Lindholm B: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990:38:495-506.
78. Sclgas R, Fedez-Reves MJ, Bosque E, et al: Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-lerm study. Am J Kidney Dis 1994:23:64-73.
79. Sclgas R, Bajo MA, Del Peso G, Jimenez C: Preserving the peritoneal membrane in longterm peritoneal dialvsis patients. Semin Dial 1995:8:326-332.
80. Fliser D, Schroder M. Neubeck M, Ritz E: Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int 1994;46: 482-488.
81. Scarpioni L, Ballochi S, Bergonzi G, Fontana F, Poisetti P, Zanazzi MA: High dose diuretics in continuous ambulatory peritoneal dialysis. Perit Dial Bull 1982;2:177-178.
82. Grantham JJ, Chonko AM: The physiologic basis and clinical use of diuretics: in Brenner BM. Stein JH (eds): Contemporary Issues in Nephrology: Sodium and Water Homeostasis. New York. Churchill Livingstone. 1978. pp 178-211.
83. Schulman G, Hakim RM: Improvingoutcomes in chronic hemodialysis patients: Should dialysis be initiated earlier? Semin Dial 1996,9:225-229.
84. Bonomini V, Feletti C, Scolari MP, Stefoni S: Early dialysis. Contrib Nephrol. Basel. Karger. 1984. vol 37, pp 45-51.
85. Bonomini V: Timing dialysis in chronic uraemic. Life Support Syst 1987;5:1-7.
86. Tattersall J, Greenwood R, Farrington K: Urea kinetics and when to commence dialysis. Am J Nephrol 1995;15:283-289.
87. Blumenkrantz MJ, Wolfson M, Kopple J: Nutritional status of patients on hemodialysis. Am J Nutr 1980;33:1567-1588.
88. Burkart JM, Nolph KD: Peritoneal dialysis; in Brenner BM (ed): The Kidney, ed 5. Philadelphia. Saunders. 1996. pp 2507-2575.
89. Churchill DN: Indications for long-term results and limitations of peritoneal dialysis; in Jacobs C. Kjellstrand CM, Koch KM, Winchester JF (eds): Replacement of Renal Function by Dialysis. ed 4. Dordrecht. Kluwer Academic Publishers. 1996, pp 603-618.
90. Wong KC, Xiong DW, Kerr PG, et al: Kt/V in CAPD by different estimations of V. Kidney Int 1995:48:563-569.
91. Tzamaloukas AH: Effect of edema on urea kinetics in peritoneal dialysis patients. Peril Dial Int 1994:14:398-401.
92. Lamcire N, Matthvs D, Matthys E, Beheydt R: Effects of long-term CAPD on carbohydrate and lipid metabolism. Clin Nephrol 1988:30 (suppl I):53-58.
93. Blake PG: Do mortality rales differ between hemodialysis and CAPD? A look at the Canadian vs. US data. Dial Transplant 1996:25:75-100.
94. Wieslander AP, Deppisch R, Svensson E. Fors-back G, Speidel R, Ripple B: In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis. Peril Dial Int 1995;15:158-164.
95. 3 modulate peritoneal macrophage antimicrobial activity in CAPD patients. Adv Peril Dial 1990:6:110-113.
96. Piraino B, Bernardini J, Holley JL, Perlmutter JA: Increased risk of Staphylococcus epidermi-dis peritonitis in patients on dialysate containing 1.25 mmol/calcium. Am J Kidney Dis 1992;19:371-374.
97. Hutchison A, Turner K, Gokal R: Effect of long-term therapy with 1.25 mmol/I calcium peritoneal dialysis fluid on the incidence of peritonitis in CAPD. Peril Dial Int 1992:12: 321-325.
98. Weinreich T, Passlick-Deetjen J, Ritz E: Low dialysate calcium in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1995:25: 452-460.
99. Weinreich T: Low or high calcium dialysate solutions in peritoneal dialysis? Kidney Int 1996;50(suppl 56):92-96.